Eris Lifesciences

Eris Lifesciences Ltd is a publicly listed Indian pharmaceutical company and is a leading player in the domestic branded formulations market. Ranked #21 in the IPM, Eris has established a leading presence in its core cardio-metabolic franchise in just 16 years from inception. Eris is also successfully diversifying its business with 3 emerging therapies (Dermatology, Neuropsychiatry and Gynaecology) accounting for 26% of its revenue. We began our journey 16 years ago in 2007 with the vision to make a meaningful impact in the management of chronic lifestyle related diseases. Today Chronic and Sub-chronic therapies account for ~ 87% of our revenue, and our product range spans ~ 90% of India’s Rs. crore chronic care market. Our business model is pivoted around specialist/ super specialist doctors and high end consulting physicians. We consistently endeavour to channel the advantages of cutting-edge medical knowledge to aid our clinicians and patients with better disease management options and outcomes